90732209
May 25, 2021
pharmaceuticals, namely, live biotherapeutics for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of cancer; pharmaceuticals, namely, live biotherapeutics for the treatment of gastrointestinal diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of central nervous system diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; pharmaceutical preparations of microorganisms for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases
PharmaceuticalsScientific research and development; pharmaceutical research and development; microbiology research and development into live biotherapeutics
Computer and Scientific